| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.1 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |